Uriach partners with ICG to support the company’s ongoing transformation and accelerate future growth
Uriach, a family-owned company founded in 1838, announced that it has entered into a strategic partnership with ICG. The newly formed alliance comes as a result of the transformation that Uriach has undergone over the last decade, focusing its strategy on the Natural Consumer Healthcare business, including the professionalization of its governance and management bodies and its accelerated international growth, with several acquisitions in different countries. As a result, Uriach has become a leading European platform within its industry.
After ten years of strong growth, and in order to further its transformation and accelerate the company’s future progress, Uriach’s decision to partner with ICG marks a strategic and long-term milestone. ICG’s partnership brings not only the financial support to enhance Uriach’s growth plan, but also its deep sector investment expertise, which will support the company’s growth activity and prepare the business for even more ambitious challenges in the future.
Enrique Uriach, Chairman of the Owner’s Council and Uriach family representative, said about partnering with ICG: “ICG represents an ideal financial partner for a family business like ours. As part of our new partnership, we will be able to execute on our ambitious plans for the future, unlocking the next phase of growth for Uriach.”
Luis Cantarell, Chairman of the Board of Directors of Uriach, adds that: “ICG’s partnership represents an important milestone in the evolution of Uriach. We are delighted that ICG will be joining the Board and supporting us as we continue to diversify and scale our business.”
Jaime Chocrón, Managing Director and Head of ICG in Iberia, said: “We are delighted to partner with Uriach, a market-leading company with an entrepreneurial management team with a clear strategy, a diversified product portfolio, a proven track record and great growth potential. By putting the consumer at the center of its strategy, Uriach has been able to capitalize on mega trends pushing the industry towards the new healthcare paradigm. We look forward to supporting Uriach in accelerating its growth as it continues to lead this sector in Europe.”
With over $82 billion in assets under management and a global presence, ICG provides flexible capital solutions to companies to support development and growth. ICG’s partnership will focus on helping Uriach grow and scale successfully, both organically and inorganically, as it reinforces its position as the leading Natural Consumer Healthcare business in Europe.
About Uriach:
Uriach is a company that believes in the power of nature, enhanced by science, as the best and most sustainable way to improve human health and well-being. Uriach wants to positively impact people's lives and the planet. That is why we are 100% focused on Natural Consumer Healthcare. We offer the consumer the best natural products, based on solid science and innovation.
With a history going back 185 years of our iconic international brands with a presence in the main European markets include Aquilea, Fisiocrem, Laborest, Aerored, Fave de Fuca, Utabon, Biodramina and Halibut,. Today, Uriach has more than 850 employees. We have subsidiaries in Spain, Italy, Portugal, Germany, Austria, Switzerland, Romania and France, and we sell our products in more than 20 other countries.